|
Report Date : |
03.05.2014 |
IDENTIFICATION DETAILS
|
Name : |
BRUKER BIOSPIN AG |
|
|
|
|
Registered Office : |
Industriestrasse 26 8117 Fällanden/ZH Switzerland/CH |
|
|
|
|
Country : |
Switzerland |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
24.06.1965 |
|
|
|
|
Com. Reg. No.: |
020.3.924.534-8 / 431763 |
|
|
|
|
Legal Form : |
Company limited by shares |
|
|
|
|
Line of Business : |
|
|
|
|
|
No. of Employees |
530 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2014
|
Country Name |
Previous Rating (31.12.2013) |
Current Rating (31.03.2014) |
|
Switzerland |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
SWITZERLAND ECONOMIC OVERVIEW
Switzerland is a peaceful, prosperous, and modern market economy with low unemployment, a highly skilled labor force, and a per capita GDP among the highest in the world. Switzerland's economy benefits from a highly developed service sector, led by financial services, and a manufacturing industry that specializes in high-technology, knowledge-based production. Its economic and political stability, transparent legal system, exceptional infrastructure, efficient capital markets, and low corporate tax rates also make Switzerland one of the world's most competitive economies. The Swiss have brought their economic practices largely into conformity with the EU's to enhance their international competitiveness, but some trade protectionism remains, particularly for its small agricultural sector. The fate of the Swiss economy is tightly linked to that of its neighbors in the euro zone, which purchases half of all Swiss exports. The global financial crisis of 2008 and resulting economic downturn in 2009 stalled export demand and put Switzerland in a recession. The Swiss National Bank (SNB) during this period effectively implemented a zero-interest rate policy to boost the economy as well as prevent appreciation of the franc, and Switzerland's economy began to recover in 2010. The sovereign debt crises currently unfolding in neighboring euro-zone countries pose a significant risk to Switzerland's financial stability and are driving up demand for the Swiss franc by investors seeking a safe-haven currency. The independent SNB has upheld its zero-interest rate policy and conducted major market interventions to prevent further appreciation of the Swiss franc, but parliamentarians have urged it to do more to weaken the currency. The franc's strength has made Swiss exports less competitive and weakened the country's growth outlook; GDP growth fell below 2% per year during 2011-13. Switzerland has also come under increasing pressure from individual neighboring countries, the EU, the US, and international institutions to reform its banking secrecy laws. Consequently, the government agreed to conform to OECD regulations on administrative assistance in tax matters, including tax evasion. The government has renegotiated its double taxation agreements with numerous countries, including the US, to incorporate the OECD standard, and is considering the possibility of imposing taxes on bank deposits held by foreigners. These steps will have a lasting impact on Switzerland's long history of bank secrecy
|
Source
: CIA |
BRUKER BIOSPIN AG
Industriestrasse
26
8117 Fällanden/ZH
Switzerland/CH
Telephone: 044
8259111
Fax: 044
8259696
Web
site: http://www.bruker.com
E-mail: info@bruker.ch
WIN
Worldbox No.: CH0000444189
VAT-No.: CHE101138357
Established: 1965
Line
of Business: Measurement and
control technology, Medical technology
Industry
Division: Manufacturing
Industry-code (NACE): 2651 Manufacture of instruments and appliances
for measuring, testing and navigation
2660 Manufacture of irradiation,
electromedical and electrotherapeutic equipment
Import/Export: Import, Export
Quality
certification: ISO 9001:2008
Banks: CS Credit Suisse
Coverage: Company
Figures: estimated
Employees: 530
The company is engaged in the production and
sale of scientific devices as well as the planning and construction of research
plants and institutes, in particular in the sector of the magnetic resonance.
Real
Estate: The company owns
buildings.
Company
No: 020.3.924.534-8 / 431763
Legal
form: Company limited by
shares
Registration: 24.06.1965
Legal
status: active
Responsible
Register: Handelsregister des Kantons
Zürich
History: Date of Statutes:
10.04.1981
Date of
Statutes: 26.11.2013
Date of
Statutes: 13.02.2008
Date of
Statutes: 20.12.2007
Date of
Statutes: 26.09.2001
Date of
Statutes: 16.06.1998
Date of
Statutes: 21.03.1997
Entry Deleted Name
05.10.2001 Bruker
BioSpin AG
26.06.1998 Spectrospin AG
26.06.1998 05.10.2001 Bruker AG
Entry Deleted Legal domicile
active Fällanden,
Switzerland
Entry Deleted Address
active Industriestrasse
26, 8117 Fällanden, Switzerland/CH
Entry Deleted Capital
active Share
Capital CHF 5,000,000, paidup CHF 5,000,000
Entry Deleted Capital Structure
05.10.2001 50,000
Registered shares of CHF 100.--
Entry Deleted Activity (original Language)
03.12.2013 Die
Gesellschaft bezweckt die Fabrikation und den Vertrieb von wissenschaftlichen
Geräten, Erwerb und Auswertung von Patenten, Beteiligung an Unternehmen
ähnlicher Art, Planung und Bau von Forschungsanlagen und Instituten,
insbesondere auf dem Gebiete der magnetischen Resonanz. Die Gesellschaft kann
auch Finanzierungen für eigene oder fremde Rechnung vornehmen sowie
Sicherungsgeschäfte, einschliesslich Garantien, Pfandbestellungen,
Globalzessionen, Sicherungsübereignungen und Schadloshaltungserklärungen, für
verbundene Unternehmen und Dritte eingehen, auch wenn diese in deren
ausschliesslichem Interesse liegen. Die Gesellschaft wahrt dabei auch die
Interessen der Bruker Corporation (USA) und der gesamten Bruker-Gruppe, soweit
dies nach zwingendem Recht zulässig ist. Die Gesellschaft kann Zweigniederlassungen
und Tochtergesellschaften im In- und Ausland errichten und sich an anderen
Unternehmen im ln- und Ausland beteiligen. Die Gesellschaft kann Grundstücke
erwerben, halten und veräussern. Die Gesellschaft kann alle kommerziellen,
finanziellen und anderen Tätigkeiten ausüben, welche mit dem Zweck der
Gesellschaft im Zusammenhang stehen.
19.02.2008 03.12.2013 Die Gesellschaft bezweckt die Fabrikation und
den Vertrieb von wissenschaftlichen Geräten, Erwerb und Auswertung von
Patenten, Beteiligung an Unternehmen ähnlicher Art, Planung und Bau von
Forschungsanlagen und Instituten, insbesondere auf dem Gebiete der magnetischen
Resonanz. Die Gesellschaft kann auch Finanzierungen für eigene oder fremde
Rechnung vornehmen sowie Sicherungsgeschäfte, einschliesslich Garantien,
Pfandbestellungen, Globalzessionen, Sicherungsübereignungen und
Schadloshaltungserklärungen, für verbundene Unternehmen und Dritte eingehen,
auch wenn diese in deren ausschliesslichem Interesse liegen. Die Gesellschaft
kann Zweigniederlassungen und Tochtergesellschaften im In- und Ausland
errichten und sich an anderen Unternehmen im In- und Ausland beteiligen. Die
Gesellschaft kann Grundstücke erwerben, halten und veräussern. Die Gesellschaft
kann alle kommerziellen, finanziellen und anderen Tätigkeiten ausüben, welche
mit dem Zweck der Gesellschaft im Zusammenhang stehen.
Entry Deleted Remarks (original Language)
active Publishing
authority: SHAB.
21.11.2006 Transfer
of Assets: Die Gesellschaft überträgt gemäss Vertrag vom 17.08.2006 Aktiven von
CHF 4.-- auf die Bruker BioSpin International AG, in Zug (CH-170.3.012.524-6).
Gegenleistung: CHF 4.--.
27.03.1997 Reports:
Mitteilungen an die Aktionäre erfolgen, sofern die Adressen sämtlicher
Aktionäre bekannt sind, rechtsgültig mit eingeschriebenem Brief, andernfalls
durch Veröffentlichung im SHAB.
Title Name
President Thomas
Bachmann, Origin: Buchholterberg, Switzerland, Residential address: Zollikon,
Switzerland, joint signature of two, Registered since: 07.01.2014
Director Dr. Bernd
Gewiese, Origin: Germany, Residential address: Straubenhardt , Germany, joint
signature of two, Registered since: 08.07.2008
Director Dr. Werner
E. Maas, Origin: Netherlands, Residential address: Merrimac /MA, United States
of America, joint signature of two, Registered since: 08.07.2008
Title Name
Director Dr. René
Jeker, Origin: Büsserach, Switzerland, Residential address: Hombrechtikon,
Switzerland, joint signature of two, Registered since: 01.10.1997
Director Dr. Rainer
Kümmerle, Origin: Germany, Residential address: 8620 Wetzikon /ZH, Switzerland,
joint signature of two, Registered since: 17.05.2010
Director Stephan
Westermann, Origin: Germany, Residential address: Bergneustadt , Germany, joint
signature of two, Registered since: 23.09.2013
Vice-Director Dr. Daniel
Eckert, Origin: Basel, Switzerland, Residential address: 8184 Bachenbülach/ZH,
Switzerland, joint signature of two, Registered since: 17.05.2010
Vice-Director Volker Ilg,
Origin: Germany, Residential address: Zollikon, Switzerland, joint signature of
two, Registered since: 23.09.2013
Vice-Director Pietro Lendi,
Origin: Uznach, Switzerland, Residential address: 8730 Uznach/SG, Switzerland,
joint signature of two, Registered since: 17.05.2010
Vice-Director Remo Lüchinger,
Origin: Oberriet SG, Switzerland, Residential address: Zürich, Switzerland,
joint signature of two, Registered since: 17.05.2010
Vice-Director Dr. Daniel
Oberli, Origin: Willisau, Switzerland, Residential address: 8610 Uster/ZH,
Switzerland, joint signature of two, Registered since: 27.04.2011
Title Name
Auditor Ernst
& Young AG, Residential address: Zürich, Switzerland, Id: CHE-491.907.686,
Registered since: 17.11.2000
Consolidation: consolidated
Industry: Trade/Industry
Fiscal year end: 31.12.2012 31.12.2011 31.12.2010 31.12.2009
Number of months: 12 12 12 12
Currency: th.
USD th. USD th. USD th. USD
Intangible fixed
assets 232,900.0 236,600.0 234,400.0 52,400.0
Tangible fixed
assets 283,600.0 249,000.0 233,700.0 223,400.0
Financial fixed
assets 0.0 0.0 0.0 0.0
other fixed assets 30,200.0 30,800.0 30,600.0 22,700.0
Fixed assets 546,700.0 516,400.0 498,700.0 298,500.0
Stocks 611,500.0 576,200.0 511,000.0 422,800.0
Liquid assets 310,600.0 246,000.0 230,400.0 207,100.0
Current assets 1,309,700.0 1,194,100.0 1,051,100.0 873,500.0
Total assets 1,856,400.0 1,710,500.0 1,549,800.0 1,172,000.0
Total shareholders
equity 706,600.0 621,500.0 524,700.0 417,200.0
Minority interests 3,100.0 3,400.0 2,700.0 1,600.0
long term debt
(financial debts) 331,700.0 215,300.0 81,700.0 109,700.0
Provisions 60,000.0 39,200.0 39,400.0 27,700.0
Other non current
liabilities 73,200.0 75,300.0 69,800.0 75,600.0
Non current
liabilities 464,900.0 329,800.0 190,900.0 213,000.0
Current
liabilities 681,800.0 755,800.0 831,500.0 540,200.0
Shareh. equity,
min. interests + liabilities 1,856,400.0 1,710,500.0 1,549,800.0 1,172,000.0
Net sales 1,791,400.0 1,651,700.0 1,304,900.0 1,114,500.0
Operating result 182,300.0 156,200.0 156,300.0 137,500.0
Result for the
financial year 77,500.0 92,300.0 95,400.0 81,200.0
Name: Bruker Corporation
City/Country: Billerica/Massachusetts, United
States of America/US
No.
of Owner/-s: 1
Owner: The company is foreign
owned.
Class: 100%
Type: direct
Name: Bruker Invest AG
City/Country: Fällanden/ZH, Switzerland/CH
Interest: 100,00% voting right,
100,00% capital interest
Class: 50-100%
Type: indirect, Group-Level
1
Name: Bruker Corporation
City/Country: Billerica/Massachusetts, United
States of America/US
Name: Bruker BioSpin
International AG
City/Country: Fällanden/ZH, Switzerland/CH
It is believed that the company has no
investments.
Control date Year No. Amount CHF Status
04.04.2014 2014 0
04.04.2014 2013 0
04.04.2014 2012 0
04.04.2014 2011 0
04.04.2014 2010 0
04.04.2014 2009 0
An updated legal action check is only
available against proof of interest. e.g. a copy of an enquiry letter, and
order or invoice relating to the subject company.
Debt Collection Case:
SEP 2013: CHF 4'042.00.
Financial
Statements: The company does not
disclose any financial statements. Third parties are not permitted any insight
into the financial affairs. It is therefore difficult to make a proper
assessment of the actual situation.
Financial
Situation: The financial situation
is considered to be good.
Payment
experiences: Payments are made with
arranged conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.23 |
|
|
1 |
Rs.101.68 |
|
Euro |
1 |
Rs.83.46 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
NIS |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.